The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Vance Terry since 2013.
This trader's CIK number is 1572282.
At the time of last reporting, Vance Terry was the Director of Enanta Pharmaceuticals Inc. (stock ticker symbol ENTA).
Also see all insider trading activities at Enanta Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ENTA | 0 | $0 | 15,295 | $139,490 | 0 | $0 |
| 2016 | ENTA | 2,000 | $54,080 | 0 | $0 | 0 | $0 |
| 2013 | ENTA | 13,295 | $186,130 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-13 | ENTA | Sale | 15,295 | 9.12 | 139,490 |
| 2016-02-12 | ENTA | Buy | 2,000 | 27.04 | 54,080 |
| 2013-03-26 | ENTA | Buy | 13,295 | 14.00 | 186,130 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vance Terry (Director of Enanta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.